0001437749-18-006795.txt : 20180412 0001437749-18-006795.hdr.sgml : 20180412 20180412211548 ACCESSION NUMBER: 0001437749-18-006795 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180402 FILED AS OF DATE: 20180412 DATE AS OF CHANGE: 20180412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDREWS RONALD ASBURY CENTRAL INDEX KEY: 0001299153 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 18753025 MAIL ADDRESS: STREET 1: 5791 VAN ALLEN WAY CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER NAME: FORMER CONFORMED NAME: Andrews Ronald Asbury DATE OF NAME CHANGE: 20040730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-775-0515 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 3 1 rdgdoc.xml FORM 3 X0206 3 2018-04-02 0 0001642380 OncoCyte Corp OCX 0001299153 ANDREWS RONALD ASBURY C/O ONCOCYTE CORPORATION 1010 ATLANTIC AVENUE, SUITE 102 ALAMEDA CA 94501 1 Option to Purchase Common Stock 2.1000 2028-04-01 Common Stock 20000 D Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant on April 2, 2018. /s/ Ronald A. Andrews 2018-04-12